Is there a protective role of progestogens on the proliferation of human ovarian cancer cells in the presence of growth factors?

European Journal of Gynaecological Oncology

Volumn 27, Issue 2, 2006, Pages 139-141

  Seeger, H ^a   Wallwiener, D ^a   Mueck, A O ^a  

^a University Women's Hospital   (Germany)

Author keywords

Growth factors; Human ovarian cancer cells; Medroxyprogesterone acetate; Norethisterone; Progesterone; Proliferation

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GESTAGEN; GROWTH FACTOR; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; PROGESTERONE; SOMATOMEDIN C;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; INCUBATION TIME; OVARY CANCER;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS, HORMONAL; CELL LINE, TUMOR; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MEDROXYPROGESTERONE 17-ACETATE; NORETHINDRONE; OVARIAN NEOPLASMS; PROGESTINS; PROTECTIVE AGENTS;

EID: 33645996320     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ho S.-M.: "Estrogen, progesterone and epithelial ovarian cancer". Reprod. Biol. Endocrinol., 2003, 1, 73.
2. Writing Group for the Women's Health Initiative Investigators: "Risks and benefits of estrogen plus progestin in healthy postmenopausal women". JAMA, 2002, 288, 321.
3. Auersperg, N., Wong, A.S.T., Choi K.-C., Kang S.K., Leung P.C.K.: "Ovarian surface epithelium: Biology, endocrinology and pathology". Endocrine Reviews, 2001, 22, 255.
4. Andreotti P.E., Thornthwaite J.T., Morse I.S.: "ATP tumor chemosensitivity assay". In: Stanley P., Kricka L.J. (eds.). "Bioluminescence and Chemoluminescence: Current Status". Chichester, J. Wiley & Sons, 1991, 417.
5. Greenlee R.T., Murray T., Bolden S., Wingo P.A.: "Cancer statistics, 2000". Cancer J. Clin., 2000, 50, 7
6. Rodriguez G.C., Nagarsheth N.P., Lee K.L., Bentley R.C., Walmer D.K., Cline M. et al.: "Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-β". J. Natl. Cancer Inst., 2002, 94, 50.
7. Bu S.-Z., Yin D.-L., Ren X.-H., Jiang L.-Z., Wu Z.-J., Gao Q.-R., Pei G.: "Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines". Cancer, 1997, 79, 1944.
8. Syed V., Ho S.-M.: "Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL". Oncogene, 2003, 22, 6883.
9. Rodriguez C., Patel A.V., Calle E.E., Jacob E.J., Thun M.J.: "Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women". JAMA, 2001, 285, 1460.
10. Lacey Jr. J.V., Mink P.J., Lubin J.H., Sherman M.E., Troisi R., Hartge P. et al.: "Menopausal hormone replacement therapy and risk of ovarian cancer". JAMA, 2002, 288, 334.
11. Anderson G.L., Judd H.L., Kaunitz A.M., Barad D.H., Beresford S.A., Pettinger M. et al.: "Effects of estrogen plus progestin on gynaecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial". JAMA, 2003, 290, 1739.
12. Coughlin S.S., Giustozzi A., Smith S.J., Lee N.C.: "A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer". J. Clin. Epidemiol., 2000, 53, 367.
13. Negri E., Tzonou A., Beral V., Lagiou P., Trichopoulos D., Parazzini F. et al.: "Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies". Int. J. Cancer, 1999, 80, 848.
14. Svensson L.O., Johnson S.H., Olsson S.E.: "Plasma concentrations of medroxyprogesterone acetate, estradiol and estrone following oral administration of Klimaxil®, Trisequence®/Provera®, and Divina®. A randomised, single-blind, triple cross-over bioavailability study in menopausal women". Maturitas, 1994, 18, 229.
15. Stanczyk F.Z., Brenner P.F., Mishell D.R., Ortiz A., Gentzschein E.K.E., Goebelsmann U.: "A radioimmunoassay for norethindrone (NET): measurement of serum net concentrations following ingestion of NET-containing oral contraceptive steroids". Contraception, 1978, 18, 615.